Court MH, Hay-Kraus BL, Hill DW, Kind AJ, Greenblatt DJ (1999) Propofol hydroxylation by
dog liver microsomes: assay development and dog breed differences. Drug Metab Dispos
27:1293–1299
Craigmill A (2003) A physiologically based pharmacokinetic model for oxytetracycline residues
in sheep. J Vet Pharmacol Ther 26:55–63
Cribb A (2003) Metabolism: the cytochrome P450s of the dog. In: Whittem T (ed) 13th Biennial
Symposium of the American Academy of Veterinary Pharmacology and Therapeutics. Char-
lotte, NC, USA, pp 30–34
del Castillo JRE (2006) Population pharmacokinetic variability of feed-administered doxycycline
in swine herds with and without paracetamol. In: 19th International Pig Veterinary Congress,
Copenhagen, Denmark
FAO (2000) World watch list for domestic animal diversity, 3rd edn. UNEP FAO, Rome, Italy
Ferran AA, Kesteman AS, Toutain PL, Bousquet-Melou A (2009) Pharmacokinetic/pharmacody-
namic analysis of the influence of inoculum size on the selection of resistance inEscherichia coli
by quinolone in a mouse-thigh bacterial infection model. Antimicrob Agents Chemother
53:3384–3390
Fink-Gremmels J (2008) Implications of hepatic cytochrome P450-related biotransformation
processes in veterinary sciences. Eur J Pharmacol 585:502–509
Fleischer S, Sharkey M, Mealey K, Ostrander EA, Martinez M (2008) Pharmacogenetic and
metabolic differences between dog breeds: their impact on canine medicine and the use of
the dog as a preclinical animal model. AAPS J 10:110–119
Garcia-Villar R, Toutain PL, Alvinerie M, Ruckebusch Y (1981) The pharmacokinetics of
xylazine hydrochloride: an interspecific study. J Vet Pharmacol Ther 4:87–92
Gayrard V, Alvinerie M, Toutain PL (1999) Comparison of pharmacokinetic profiles of doramec-
tin and ivermectin pour-on formulations in cattle. Vet Parasitol 81:47–55
Gioiosa L, Chiarotti F, Alleva E, Laviola G (2009) A trouble shared is a trouble halved: social
context and status affect pain in mouse dyads. PLoS ONE 4:e4143
Glasser A, Murphy CJ, Troilo D, Howland HC (1995) The mechanism of lenticular accommoda-
tion in chicks. Vision Res 35:1525–1540
Gokbulut C, Karademir U, Boyacioglu M, McKellar QA (2008) The effect of sesame and
sunflower oils on the plasma disposition of ivermectin in goats. J Vet Pharmacol Ther
31:472–478
Gonzalez A, Sahagun AM, Diez MJ, Fernandez N, Sierra M, Garcia JJ (2006) Pharmacokinetics of
a novel formulation of ivermectin after administration to goats. Am J Vet Res 67:323–328
Guillot P, Sanders P, Mourot D (1988) Pharmacokinetic study of chloramphenicol in the rabbit.
Ann Rech Vet 19:27–33
Hansen BD (2003) Assessment of pain in dogs: veterinary clinical studies. ILAR J 44:197–205
Houston T, Chay S, Woods WE, Combs G, Kamerling S, Blake JW, Edmundson AG, Vessiney R,
Tobin T (1985) Phenylbutazone and its metabolites in plasma and urine of thoroughbred
horses: population distributions and effects of urinary pH. J Vet Pharmacol Ther 8:136–149
Hunter RP (2009) Zoological pharmacology. In: Riviere JE, Papich MG (eds) Veterinary pharma-
cology and therapeutics, 9th edn. Wiley-Blackwell, Ames, IA, pp 1343–1352
Hunter RP, Mahmood I, Martinez MN (2008) Prediction of xenobiotic clearance in avian species using
mammalian or avian data: how accurate is the prediction? J Vet Pharmacol Ther 31:281–284
Ingebrigtsen K (1991) Factors affecting drug disposition in fish. In: Friis C, Gyrd-Hansen NP,
Rsamussen F (eds) 5th congress of the European Association for Veterinary Pharmacology and
Toxicology. Copenhagen, Denmark, pp 44–56
KuKanich B, Coetzee JF, Gehring R, Hubin M (2007) Comparative disposition of pharmacologic
markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracel-
lular and total body fluid volume of Greyhound and Beagle dogs. J Vet Pharmacol Ther
30:314–319
Laffont CM, Alvinerie M, Bousquet-Me ́lou A, Toutain PL (2001) Licking behaviour and environ-
mental contamination arising from pour-on ivermectin for cattle. Int J Parasitol 31:1687–1692
46 P.-L. Toutain et al.